{
  "trial_id": "NCT00766038",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Non-penetrating TBI",
      "label": "met"
    },
    {
      "criterion": "Age 18 - 50 years",
      "label": "met"
    },
    {
      "criterion": "Admission to a North Texas Traumatic Brain Injury Model System-affiliated rehabilitation unit within 8 weeks of injury",
      "label": "met"
    },
    {
      "criterion": "Randomization within 2 - 10 weeks of injury",
      "label": "met"
    },
    {
      "criterion": "Rancho Los Amigos Rating IV or better at the time of randomization",
      "label": "met"
    },
    {
      "criterion": "GH deficiency diagnosed by either of the following two criteria: Peak GH response to L-arginine stimulation test < 1.4 microg/L; or Plasma IGF-1 level 1 SD below the expected median for age and body weight",
      "label": "unknown"
    },
    {
      "criterion": "Availability of caregiver to oversee administration of medications",
      "label": "met"
    },
    {
      "criterion": "Reasonable expectation for completion of outcome measures",
      "label": "met"
    },
    {
      "criterion": "Residence inside the United States",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "History of pre-existing neurologic disease (such as epilepsy, brain tumors, meningitis, cerebral palsy, encephalitis, brain abscesses, vascular malformations, cerebrovascular disease, Alzheimer's disease, multiple sclerosis, or HIV-encephalitis)",
      "label": "not_met"
    },
    {
      "criterion": "History of premorbid disabling condition that interfere with outcome assessments",
      "label": "unknown"
    },
    {
      "criterion": "Contraindication to rhGH therapy. (hypersensitivity to rhGH or any of the components of the supplied product, including metacresol, glycerin, or benzyl alcohol)",
      "label": "not_met"
    },
    {
      "criterion": "Penetrating traumatic brain injury",
      "label": "triggers"
    },
    {
      "criterion": "Diabetes mellitus",
      "label": "unknown"
    },
    {
      "criterion": "Obesity (BMI > 30)",
      "label": "unknown"
    },
    {
      "criterion": "Active infection",
      "label": "not_met"
    },
    {
      "criterion": "Active malignant disease",
      "label": "not_met"
    }
  ],
  "notes": "The patient has a history of acromegaly due to pituitary adenoma and underwent transsphenoidal surgery 4 months ago. His recent lab studies show an IGF-1 level of 4.5 ULN adjusted by sex and age, and his random GH level is 4 ug/L.",
  "_meta": {
    "topic_id": "56",
    "trial_id": "NCT00766038",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}